Evaluation of the tolerability and safety of a recombinant HIV-1 multi-envelope DNA plasmid vaccine (EnvDNA) in healthy adults.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs HIV DNA vaccine (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 26 Apr 2017 Biomarkers information updated
- 01 Jun 2011 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
- 01 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.